Showing results (341-350 of 468) with videos related to

Sort By:
Pageof 47
Journal of Hepatology|September 23, 2022
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosisAlberto Zanetto, Filippo Pelizzaro, Elena Campello, et al.
Hepatology Communications|September 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapyBernhard Scheiner, Katharina Lampichler, Katharina Pomej, et al.
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Infection|October 21, 2015
Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcomeChristoph Boesecke, Patrick Ingiliz, Thomas Reiberger, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosisAndrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
European Journal of Gastroenterology & Hepatology|November 10, 2017
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver diseaseStephan Moser, Karin Kozbial, Hermann Laferl, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.
United European Gastroenterology Journal|November 25, 2025
Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver-Related DeathCaroline Schwarz, Andrea Kornfehl, Reema Abid, et al.
Hepatology (Baltimore, Md.)|May 20, 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective studyStanislas Pol, Alexander J Thompson, Michelle Collins, et al.
Journal of Hepatology|June 1, 2016
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertensionMattias Mandorfer, Karin Kozbial, Philipp Schwabl, et al.
Pageof 47